In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria

Journal of Cystic Fibrosis

Volumn 9, Issue 6, 2010, Pages 450-454

  Van Acker, Heleen ^a   Van Snick, Elisabeth ^a   Nelis, Hans J ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Bactericidal; Bacteriostatic; Biofilm; Burkholderia cepacia complex; Cystic fibrosis; Temocillin

Indexed keywords

CEFTAZIDIME; MEROPENEM; TEMOCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BIOFILM; BURKHOLDERIA; BURKHOLDERIA AMBIFARIA; BURKHOLDERIA ANTHINA; BURKHOLDERIA ARBORIS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CONTAMINANS; BURKHOLDERIA DIFFUSA; BURKHOLDERIA DOLOSA; BURKHOLDERIA LATA; BURKHOLDERIA LATENS; BURKHOLDERIA METALLICA; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA PYRROCINIA; BURKHOLDERIA SEMINALIS; BURKHOLDERIA STABILIS; BURKHOLDERIA UBONENSIS; BURKHOLDERIA VIETANAMIENSIS; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BIOFILMS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS;

EID: 78650214940     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.08.015     Document Type: Article

References (19)

1. Vanlaere E., Baldwin A., Gevers D., Henry D., De Brandt E., LiPuma J.J., et al. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 2009, 59:102-111.
2. Mahenthiralingam E., Urban T.A., Goldberg J.B. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 2005, 3:144-156.
3. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
4. Conway B.A., Venu V., Speert D.P. Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J Bacteriol 2002, 184:5678-5685.
5. Committee for orphan medicinal products. Public summary of positive opinion for orphan designation of temocillin sodium (internet) 2004 Sept 23 (cited 2010 May 31). Available from: http://www.ema.europa.eu/pdfs/human/comp/opinion/164503en.pdf.
6. Livermore D.M., Tulkens P.M. Temocillin revived. J Antimicrob Chemother 2009, 63:243-245.
7. Taylor R.F., Gaya H., Hodson M.E. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia. J Antimicrob Chemother 1992, 29:341-344.
8. Lekkas A., Gyi K.M., Hodson M.E. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis. J Cyst Fibros 2006, 5:121-124.
9. Kent L., Bradley J.M., France M., Doring G., Carryn S., Bradbury I., et al. Temocillin in cystic fibrosis: a retrospective pilot study. J Cyst Fibros 2008, 7:551-554.
10. Bonacorsi S., Fitoussi F., Lhopital S., Bingen E. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 1999, 43:213-217.
11. Carryn S., Tulkens P.M., Vandamme P. Comparative in vitro activity of temocillin, meropenem, ceftazidime and piperacillin/tazobactam against panel strains and clinical isolates of Burkholderia cepacia complex from 9 different genomovars. Paper presented at: The International Burkholderia cepacia Working Group Meeting; 2006 April 20-23; Gent, Belgium 2006.
12. Lorian V. Antibiotics in Laboratory Medicine 2005, Lippincott Williams and Wilkins, Philadelphia.
13. Peeters E., Nelis H.J., Coenye T. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother 2009, 64:801-809.
14. Fuchs P.C., Barry A.L., Thornsberry C., Jones R.N. Interpretive criteria for temocillin disk diffusion susceptibility testing. Eur J Clin Microbiol 1985, 4:30-33.
15. Tomlin K.L., Coll O.P., Ceri H. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can J Microbiol 2001, 47:949-954.
16. Bauernfeind A. Bacteriostatic and bactericidal activity of penicillins at constant and variable concentrations. Drugs 1985, 29:9-14.
17. Fass R.J. Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli. Antimicrob Agents Chemother 1982, 21:1003-1006.
18. Masuda G., Tomioka S., Uchida H., Hasegawa M. Bacteriostatic and bactericidal activities of selected beta-lactam antibiotics studied on agar plates. Antimicrob Agents Chemother 1977, 11:376-382.
19. Roberts J.A., Lipman J., Blot S., Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care 2008, 14:390-396.